DRIO - DarioHealth Corp.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
9.7M
Enterprise Value 3
6.62M
Trailing P/E
N/A
Forward P/E 1
-1.59
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
1.30
Price/Book (mrq)
2.49
Enterprise Value/Revenue 3
0.89
Enterprise Value/EBITDA 6
-0.36

Trading Information

Stock Price History

Beta (3Y Monthly) -0.07
52-Week Change 3-74.69%
S&P500 52-Week Change 313.63%
52 Week High 31.0500
52 Week Low 30.2000
50-Day Moving Average 30.2720
200-Day Moving Average 30.4570

Share Statistics

Avg Vol (3 month) 393.9k
Avg Vol (10 day) 352.37k
Shares Outstanding 543.7M
Float 26.39M
% Held by Insiders 135.74%
% Held by Institutions 116.11%
Shares Short (Oct 15, 2019) 4227.76k
Short Ratio (Oct 15, 2019) 41.91
Short % of Float (Oct 15, 2019) 40.71%
Short % of Shares Outstanding (Oct 15, 2019) 40.52%
Shares Short (prior month Sep 13, 2019) 4219.43k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 218/1
Last Split Date 3Mar 4, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -248.57%
Operating Margin (ttm)-247.29%

Management Effectiveness

Return on Assets (ttm)-100.55%
Return on Equity (ttm)-259.06%

Income Statement

Revenue (ttm)7.46M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)-0.60%
Gross Profit (ttm)1.76M
EBITDA -18.27M
Net Income Avi to Common (ttm)-18.55M
Diluted EPS (ttm)-0.4080
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.58M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)764k
Total Debt/Equity (mrq)19.56
Current Ratio (mrq)1.70
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-16.31M
Levered Free Cash Flow (ttm)-9.53M